Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ACLX
Arcellx, Inc.
Healthcare | Biotechnology
No licensed closing price on file for ACLX. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (FY2025)$-4.07
Arcellx, Inc. (NASDAQ: ACLX) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 02:26 UTC.
ACLX no longer appears among SEC's registered filers -- it may have been acquired, merged, or delisted. The figures on this page reflect the company's final filings and are no longer refreshed.
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
2024-03-14AuditorChanges in registrant's certifying accountantEYEstimatedSEC 8-K →
2022-05-23Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
Arcellx, Inc. is a biotechnology company, listed on NASDAQ as ACLX.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 02:26 UTC. This page is also available as JSON at /api/data?ticker=ACLX and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ACLX and 5,000+ tickers.